Cost-effectiveness of treatment alternatives in Parkinson's disease. An evaluation using a Markov decision analytic model

被引：0
|
作者：
Dodel, R
Spottke, A
Oertel, WH
Poewe, W
Sampaio, C
Siebert, U
机构：
来源：
MOVEMENT DISORDERS | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of seven IVF strategies: results of a Markov decision-analytic model
    Fiddelers, Audrey A. A.
    Dirksen, Carmen D.
    Dumoulin, John C. M.
    van Montfoort, Aafke P. A.
    Land, Jolande A.
    Janssen, J. Marij
    Evers, Johannes L. H.
    Severens, Johan L.
    HUMAN REPRODUCTION, 2009, 24 (07) : 1648 - 1655
  • [2] Cost-effectiveness of ivf treatment in relation to female age and ovarian reserve; results of a markov decision-analytic model
    Moolenaar, L.
    Broekmans, F. B.
    van de Veen, F.
    Fauser, B. C. J. M.
    Hompes, P.
    Mol, B. W.
    HUMAN REPRODUCTION, 2010, 25 : I156 - I157
  • [3] COST-EFFECTIVENESS ANALYSIS FOR TREATMENT OF PARKINSON'S DISEASE: A SYSTEMATIC REVIEW
    Yamabe, K.
    Inoue, S.
    Kuwabara, H.
    Kobayashi, M.
    VALUE IN HEALTH, 2016, 19 (07) : A432 - A432
  • [4] Potential cost-effectiveness of intracoronary stent versus angioplasty in coronary artery disease. A Markov model
    Nichol, G
    Juergenson, L
    Higginson, LA
    Labinaz, M
    Hendry, P
    Marquis, JF
    CIRCULATION, 1997, 96 (08) : 1899 - 1899
  • [5] Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinson’s Disease in the UK SettingAn Economic Markov Model Evaluation
    Alan Haycox
    Christophe Armand
    Susana Murteira
    John Cochran
    Clément François
    Drugs & Aging, 2009, 26 : 791 - 801
  • [6] Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinson's Disease in the UK Setting: An Economic Markov Model Evaluation
    Kovacs, Norbert
    Janszky, Jozsef
    Nagy, Ferenc
    DRUGS & AGING, 2011, 28 (02) : 161 - 162
  • [7] Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinson’s Disease in the UK SettingAn Economic Markov Model Evaluation
    Norbert Kovacs
    Jozsef Janszky
    Ferenc Nagy
    Drugs & Aging, 2011, 28 : 161 - 162
  • [8] Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinson's Disease in the UK Setting An Economic Markov Model Evaluation
    Haycox, Alan
    Armand, Christophe
    Murteira, Susana
    Cochran, John
    Francois, Clement
    DRUGS & AGING, 2009, 26 (09) : 791 - 801
  • [9] Flexibility of Markov modeling for clinical pharmacoeconomics: illustration for cost-effectiveness in early Parkinson's disease
    Postma, Maarten J.
    Boersma, Cornelis
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2012, 5 (01) : 1 - 4
  • [10] COST EFFECTIVENESS OF APOMORPHINE IN THE TREATMENT OF ADVANCED PARKINSON DISEASE IN THE UK AND GERMANY: RESULTS FROM A MULTICOUNTY DECISION ANALYTIC MODEL
    Walter, E.
    Said, M.
    VALUE IN HEALTH, 2013, 16 (07) : A622 - A622
12345